Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall survival (OS).
Stress and pain linked to worse outcomes in HER2-positive breast cancer patients
- Post author:
- Post published:June 2, 2024
- Post category:uncategorized